Clinical Trial Update: Low Level Laser Treatment (LLLT) and Lorcaserin for Weight Management [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating low level laser therapy (LLLT) in combination with lorcaserin for weight management in overweight and obese individuals; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• Belviq (lorcaserin)

Snippet

Sponsor: Mayo Clinic | Conditions: Overweight, Obese | Phase 3 | Status: COMPLETED | Results posted: 2016-11-22